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Abstract: The COVID-19 pandemic has affected work and family life for many, including academic 
researchers. Anecdotal evidence suggests that university shutdowns have influenced the article submission 
rates of men and women differently. Here we present a timely analysis that compares the proportion of men 
and women medical researchers publishing on the coronavirus to those publishing in the same journals in 
2019. This is presently the most direct means of gauging gender variations in ongoing research activities. 
For clarity of context, we delimit our analysis to researchers in the United States. Using mixed-effects 
regression models, we estimate that women’s shares of first authorships, last authorships and general 
representation per author group are 23%, 16% and 16% lower for COVID-19 papers compared to 2019 
papers published in the same journals. Our findings are consistent with the idea that the research 
productivity of women, especially early-career women, is being affected more than the research 
productivity of men. 
Introduction 
During the COVID-19 pandemic, many governments have shuttered schools and implemented social 
distancing requirements that limit options for childcare, while simultaneously requiring researchers to work 
from home (Minello, 2020). Robust evidence suggests that women in academic medicine shoulder more of 
the burden of domestic labor within their households than do men. One study of an elite sample of NIH-
funded physician-researchers showed that women spent 8.5 hours more per week on parenting and domestic 
tasks than their men peers (Jolly et al., 2014). Recent research also suggests that women in academia take 
on more domestic responsibilities than men, even in dual-career academic couples (Derrick et al., 2019). 
Therefore, the recent restrictions in access to childcare might reasonably be expected to have 
disproportionate impact on women in academic medicine, as compared to men. The impact of new 
professional service demands that now compete with time for scholarly productivity in academic medicine, 
including restructuring of teaching and clinical care using virtual platforms, may also disproportionately 
impact women medical researchers, who are disproportionately represented on clinician-educator tracks .  
Here, we focus on the published medical research literature, where it may be possible to provide an early 
evaluation of whether the gender gap in academic productivity is widening. The medical literature now 
includes a substantial number of articles directly relating to COVID-19, mostly generated rapidly after the 
broader social restrictions came into being, in most US states, in March 2020. Therefore, we report the 
results of a global analysis of possible variations in women’s proportion of authorships of articles on 
COVID-19 (N = 9,050), as compared to the proportion of women among authorships of all articles 
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published in the same journals the previous year (N = 193,098). Specifically, we used mixed logit and tobit 
models with scientific journal as random effect parameter, to estimate women’s share of first authorships 
(logit), last authorships (logit) and proportional representation per article (tobit), for Covid-19 papers 
(treatment) and papers published in the same journals in 2019 (control).  
Results 
Panels a, b and c (figure 1) juxtapose the observed proportion of women authorships (bars) for COVID-19 
papers and for papers published in the same journals in 2019. This descriptive analysis suggests that the 
proportion of women publishing as first authors and last authors has decreased by 23% and 12%, 
respectively, after the outbreak of the Pandemic (COVID-19 sample: first authorships, arithmetic mean= 
0.28; last authorships, arithmetic mean: 0.23; 2019 sample: first authorships, arithmetic mean= 0.36; last 
authorships, arithmetic mean: 0.26), while the overall share of women per author group has decreased by 
11% (COVID-19 sample: arithmetic mean= 0.30; 2019 sample: arithmetic mean= 0.34).  
The crosses and error-bars in figure 1 (panels a and b) plot the adjusted means derived from the mixed logit 
models that control for variations in COVID-19 related research activities across scientific journals and 
show that women’s estimated share of first authorships and last authorships is 23% and 16% lower in the 
COVID-19 sample (first authorships, adjusted mean= 0.28, CI: 0.25-0.31; last authorships, adjusted mean: 
0.22, CI: 0.20-0.25) compared to the 2019 sample (first authorships, adjusted mean: 0.37, CI: 0.35-0.38; 
last authorships, adjusted mean: 0.27, CI: 0.25-0.28). Likewise, the outcomes of the mixed tobit model, 
plotted in panel c (figure 1), indicate that women’s estimated general representation per article is 16% lower 
in the COVID-19 sample (adjusted mean: 0.30, CI: 0.27-0.32) compared to the 2019 sample (adjusted 
mean: 0.35, CI: 0.34-0.37) (see Figure 1- source data 1 to 3 for model specifications). 
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Figure 1: Observed (bars) and estimated (crosses and error-bars) proportions of women among authors of 1,179 U.S. papers 
on COVID-19 and 37,531 papers published in the same journals in 2019. The bars show differences in the observed 
proportions of women in different author positions (a and b) and for the complete author list (c), for papers published in 
2020 COVID-19 papers (blue bars) versus papers from the same journals in 2019 (orange bars). All three panels show a 
decrease in the observed proportion of women. The crosses and error-bars laid over the bars report the adjusted means 
and 95% confidence intervals derived from mixed logit and tobit models with scientific journal as random effect parameter. 
To obtain a closer approximation of differences across research areas, we calculated the proportion of 
women authorships per journal specialty. As shown in Table 1, women are represented at lower rates across 
most specialty groupings in the COVID-19 sample as compared to the 2019 sample. The relative gap in 
women’s participation is most salient in infectious diseases, radiology, pathology, and public health. 
Importantly, none of these groups show extreme deviations variations from the overall trend. This indicates 
that the observed differences are not due to a specialty bias, where specialties with a high representation of 
men produce the majority of COVID-19 research. 
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2019 papers 
  
COVID-19 papers 
  
 
Proportion of women 
 
 
 
Proportion of women 
Journal specialty N  First 
author 
Full 
group 
Last 
author 
 N  First 
author 
Full 
group 
Last 
author 
Dermatology 582  0.45 0.47 0.37  46  0.35 0.41 0.28 
Emergency medicine 786  0.34 0.33 0.23  41  0.29 0.29 0.15 
High impact general medicine 949  0.35 0.40 0.32  101  0.33 0.39 0.37 
Infectious diseases 670  0.47 0.43 0.29  41  0.17 0.30 0.24 
Internal medicine 8,266  0.36 0.35 0.26  294  0.30 0.31 0.18 
Other basic sciences 8,948  0.37 0.35 0.25  106  0.26 0.31 0.25 
Other clinical sciences 9,040  0.39 0.39 0.30  257  0.33 0.34 0.28 
Other health professions 110  0.51 0.54 0.42  7  0.43 0.49 0.43 
Otolaryngology 904  0.32 0.29 0.19  74  0.19 0.27 0.20 
Pathology 325  0.42 0.44 0.31  31  0.23 0.33 0.32 
Public health 2,173  0.44 0.42 0.32  53  0.23 0.33 0.23 
Radiology 1,209  0.32 0.32 0.24  39  0.18 0.29 0.08 
Surgery 3,569  0.23 0.23 0.13  89  0.22 0.20 0.11 
Table 1. Number of observations, N,  and proportion of women by author list position for journals grouped by their 
specialty. The grouped columns show results by journal category for COVID papers published in 2020 (four rightmost 
columns) in contrast to papers from the same journals in 2019. Only papers with at least one US address in the affiliations 
and clear gender for first and last author are included. 
Discussion 
Prior research has raised concerns about women’s underrepresentation among authors of medical research, 
including both original research and commentaries (Clark et al., 2017; Hart and Perlis, 2019; Jagsi et al., 
2006; Larson et al., 2019; Silver et al., 2018). Our analysis suggests that the COVID-19 pandemic may be 
amplifying this gender gap in the medical literature. Specifically, we find that women constitute a lower 
proportion of authors of articles on COVID-19, as compared to the proportion of women among authors of 
all articles published in the same journals the previous year. The difference in women’s participation before 
and after the pandemic is most striking for first authorships. This finding is consistent with the idea that 
restricted access to child-care and increased work-related service demands might take the greatest toll on 
early-career women, although our observational data cannot conclusively support causal claims. As more 
robust evidence becomes available, mechanisms which disadvantage specific ethnic, age and gender groups 
should be monitored and inform policies that promote equity (Donald, 2020). 
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Some have argued that the authorship gender gap in academic medicine is best explained by a slow pipeline 
and the historical exclusion of women from medical school enrollment1. However, as time has passed, and 
women have reached parity in the United States and even begun to constitute the majority of the medical 
student body in many other countries, their persistently low participation as authors has raised concerns 
about bias in unblinded peer review processes and unequal opportunities prior to manuscript submission 
(Jagsi et al., 2014; Silver, 2019). Studies have demonstrated differences in the very language used by men 
and women to describe their research findings (Lerchenmueller et al., 2019), and evidence suggests that 
women’s writing may be held to higher standards (Hengel, 2017). In any case, the current study suggest 
that if authorship of COVID-19-related papers is a bellwether, women’s participation in the medical 
research literature may now be facing even greater challenges than before the pandemic, especially if 
ongoing or repeated episodes of social distancing are required as expected (Kissler et al., 2020). 
This study is limited to a relatively small sample produced early in the course of the pandemic and misses 
information on important covariates. However, descriptive analysis that breaks down our results by 
specialty does not suggest that those specialties that might dominate research related to COVID had low 
proportions of women among authors in 2019. Indeed, many such specialties, including infectious disease 
and public health, qualitatively appear to have a markedly lower proportion of women among authors in 
the 2020 COVID-related dataset than in the 2019 dataset within those fields. Therefore, despite limitations, 
this early look suggests that the previously documented gender gap in academic medical publishing may 
warrant renewed attention (Jagsi et al., 2006) and that ongoing research on this subject is necessary as more 
data become available. 
Although some may believe that diversity and equity are niceties that cannot be considered during times of 
crisis, abundant literature reveals the importance of diverse teams for solving complex problems like those 
related to COVID-19 (Nielsen et al., 2018, 2017; Phillips et al., 2014; Woolley et al., 2010). If societal 
constraints limit the talent pool who may contribute to research informing the crisis response, the 
consequences will be profound indeed. Policies to support full inclusion of diverse scholars and 
transformation of norms for dividing labor appear to be urgent priorities.  
 
1 Association of American Medical Colleges. Medical students, selected years, 1965-2013, 2019. Available: 
http://www.aamc.org/ download/411782/data/2014_table1.pdf. 
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Materials & methods 
On May 9th 2020, we searched PubMed Medline for papers including “COVID-19” or “SARS-CoV2” in 
the title or abstract, to identify publications most likely generated after pandemic-related societal changes 
developed. This resulted in 9,054 articles, of which only 4 were published prior to 2020. We extracted 
journal information and matched the 2020 papers [treatment] to 2019 papers [control] from the same 
journals (N = 193,098). Only journals with at least 5 papers on COVID-19 were included in the analysis 
(443 of 1,823 journals (24.3%), 6,734 of 9,050 papers (74.4%)). We extracted author names for both 
treatment and control, and used these to determine author gender as in prior work (Andersen et al., 2019). 
Gender was reliably estimated for 81.9% of the entire sample. For the papers with at least one US author, 
gender could be established for 89.4% of first authors and 90.5% of last authors. Only papers with gender 
reliably identified for first and last authors were included. Limiting the sample further to papers with at 
least one author with a US address, with gender determined for authors, gives us a treatment group of 1,179 
papers (13.0%) and a control group of 37,531 papers (19.4%). The treatment group is relatively smaller, 
because proportionally more COVID-19 research has been done by researchers outside the US, especially 
those in China and Italy.  
As a robustness check, we selected a random sample of 300 publications from the treatment group and 
looked up information supplied by the publishers on submission and publication dates. Far from all 
publishers offer this information and to our knowledge there are no databases gathering this information 
consistently. Thus, we were able to find submission dates for 153 (51.0%) of the 300 publications. Of these, 
129 (84.3%) were submitted after March 15th, 2020, and 276 of the 300 (92.0%) were published after this 
date. 
We calculated the general proportion of women per author group (f_share) for all papers included in the 
analysis. If we could not determine the gender of one or more authors, these were left out of the equation, 
so as to not skew the average share towards one gender. f_share values range from 0 to 1, with values closer 
to 1 indicating a higher proportion of women in the paper’s byline.  
We used mixed logit and tobit models to estimate women’s share of authorships Covid-19 papers 
(treatment) and papers published in the same journals in 2019 (control). We included scientific journal as 
random effect parameter to adjust for variations in COVID-related research activities across scientific 
journals. 
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The mixed tobit regression was used to estimate the relationship between the dichotomous intervention 
variable (2019 sample=0, COVID-19 sample=1) and women’s overall representation per article (f_share). 
The tobit model was specified with a left-censoring at 0 and a right-censoring at 1, and computed with 
robust standard errors. We used multilevel logistic regressions to estimate the relationship between the 
intervention variable and women’s share of first authorships (outcome variable: man=0, woman=1) and last 
authorships (outcome variable: man=0, woman=1). The statistical analyses were conducted in STATA 16 
and R version 4.0.0. For the multilevel tobit and logit regressions, we used the “metobit” and “melogit” 
mixed effects routines in STATA. To produce the figures, we used the R package ggplot2 v. 3.3.0.  
The relative differences in observed and adjusted proportions were calculated with six decimals. 
To produce Table 1, we manually categorized journals by specialty. Four authors participated in grouping 
the journals, with at least two independently coding every journal, and with discrepancies addressed by 
team consensus. 
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Figure 1 Source data 1. Mixed Tobit Model Predicting the overall share of women per article, using journals as random effects 
and treatment [intervention] as fixed effect.   
Coef. SE (robust) 95% CI 
 
Fixed Intercept .354 .007 .339 .369 
 
Intervention (dummy) -.056 .010   -.075            -.036 
Random Journal (intercept) .013 .002 .010 .016 
Intra-class corr. Journal          0.159 0.170 0.128        0.195 
 
Number of disciplines 250 
   
 
Number of respondents 38,710 
   
 
Log Likelihood (fixed effects model)        -8453.0067   
  
 Log Pseudo-likelihood (full model)        -5884.0835    
Note: The model is computed with robust standard errors.  
 
Figure 1 Source data 2. Mixed logit model with firs-author gender as outcome (woman=1) , using journals as random 
effects and treatment [intervention] as fixed effect.   
Coef. SE (robust) 95% CI 
 
Fixed Intervention (dummy) -.414 .069   -
.548    
-.279 
Random Journal (constant) .270 .030 .22 .336 
Intra-class corr. Journal .076 .008 .068           .093 
      
 
Number of disciplines 250 
   
 
Number of respondents 38,710 
   
 
Log Likelihood (fixed effects model) -
25286.986 
  
  
 Log likelihood (full model) -
24469.623 
   
 
Figure 1 Source data 3 
. Mixed logit model with last-author gender as outcome (woman=1) , using journals as random effects and treatment 
[intervention] as fixed effect.   
Coef. SE (robust) 95% CI 
 
Fixed Intervention (dummy) -.250 .074   -.394    -.105 
Random Journal (constant) .381 .043 .306 .475 
Intra-class corr. Journal .104 .010 .085 .126 
      
 
Number of disciplines 250 
   
 
Number of respondents 38,710 
   
 
Log Likelihood (fixed effects model) -22162.618   
  
 Log likelihood (full model) -21278.292    
 
